<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01441583</url>
  </required_header>
  <id_info>
    <org_study_id>CR-CL-07202011-B-H</org_study_id>
    <nct_id>NCT01441583</nct_id>
  </id_info>
  <brief_title>Ingenio Device Algorithm Study</brief_title>
  <acronym>IVORY</acronym>
  <official_title>Ingenio Device Algorithm Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the IVORY Study is to gather data to support global submissions/approvals for
      some models of the Ingenio device family.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      IVORY is a prospective, multi-center, randomized within-patient, single-blinded study to
      gather data to support Right Atrial Auto Threshold and RYTHMIQ
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of Commanded Right Atrial Automatic Threshold (RAAT)</measure>
    <time_frame>3 months post implant</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>System-related Complication-free rate</measure>
    <time_frame>90 days post-implant</time_frame>
    <description>a complication related to the system, when the patient is implanted with a pacemaker device
a complication related to the system, save for the LV lead, when the patient is implanted with a CRT-P</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy of Ambulatory Right Atrial Automatic Threshold</measure>
    <time_frame>3 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appropriate RAAT Test Outcome</measure>
    <time_frame>3 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RYTHMIQ</measure>
    <time_frame>3 months post implant</time_frame>
    <description>Chronic success for this effectiveness endpoint will be assessed by a median relative reduction of RV pacing percent (RVPP) for RYTHMIQ programmed to ON vs. RYTHMIQ programmed to OFF. All patients will receive both RYTHMIQ programmed to ON and programmed to OFF in two consecutive periods, where the patient's programming allocation will be randomized for the first period. Then a crossover to the alternate setting will occur for the second period once the end of the first period is reached.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RAAT Pace Output Margin</measure>
    <time_frame>3 months post implant</time_frame>
    <description>The purpose of this endpoint is to demonstrate that the RAAT algorithm produces a sufficient pacing output voltage that is able to capture the right atrium</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">139</enrollment>
  <condition>Sinus Node Disease</condition>
  <condition>AV Block</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>RYTHMIQ Off at Pre-discharge, On at 1-Month</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For the RYTHMIQ endpoint only, subjects implanted with a pacemaker will be randomized. Those randomized to RYTHMIQ Off at Pre-Discharge will have RYTHMIQ programmed Off until their 1-month follow up, when they will be crossed over to RYTHMIQ On until their 3-month follow up.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RYTHMIQ On at Pre-Discharge, Off at 1-Month</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For the RYTHMIQ endpoint only, subjects implanted with a pacemaker will be randomized. Those randomized to RYTHMIQ On at Pre-Discharge will have RYTHMIQ programmed On until their 1-month follow up, when they will be crossed over to RYTHMIQ Off until their 3-month follow up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RAAT</intervention_name>
    <description>For Pacemaker and CRT-P: Right Atrial Automatic Threshold (RAAT)</description>
    <arm_group_label>RYTHMIQ Off at Pre-discharge, On at 1-Month</arm_group_label>
    <arm_group_label>RYTHMIQ On at Pre-Discharge, Off at 1-Month</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RYTHMIQ</intervention_name>
    <description>For pacemakers only: RYTHMIQ RYTHMIQ randomized to on at pre-discharge or at 1-month, depending on assignment</description>
    <arm_group_label>RYTHMIQ Off at Pre-discharge, On at 1-Month</arm_group_label>
    <arm_group_label>RYTHMIQ On at Pre-Discharge, Off at 1-Month</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who are willing and capable of providing informed consent to undergo a device
             implant and to participate in all testing associated with this clinical study;

          -  Subjects whose age is 18 or above, or of legal age to give informed consent specific
             to national law;

          -  Subjects indicated for a dual chamber pacemaker or a CRT-P device according to class I
             or class II indications of the standard ESC or ACC / AHA implant guidelines;

          -  Subjects who are planned to be implanted with all leads intended for a specific device
             type (dual chamber pacemaker: atrial and right ventricular lead, CRT-P: atrial, right
             and left ventricular lead) or are already implanted with such leads;

          -  Subjects who receive or are implanted with a bipolar atrial lead.

        Exclusion Criteria:

          -  Women of childbearing potential who are or might be pregnant at the time of the study
             (method of assessment upon physician's discretion);

          -  Enrolled in any other concurrent study, with the exception of local mandatory
             governmental registries and observational studies/registries that are not in conflict
             or affect

          -  Schedule of procedures for IVORY (i.e. should not cause additional or missed visits);

          -  Programming of devices for IVORY per CIP;

          -  IVORY outcome (i.e. involve medications that could affect the heart rate of the
             subject);

          -  Conduct of IVORY per GCP / ISO 14 155:2011 / local regulations.

          -  Subjects who live at such a distance from the clinic that travels for FU visits at a
             study center would be unusually difficult or burdensome for the subject;

          -  Inability or refusal to comply with the FU schedule;

          -  A life expectancy of less than 12 months, per physician discretion;

          -  Subjects who are planned to be programmed to a pacing mode other than DDD / DDDR
             during the study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy S Gardner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Golden Jubilee National Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens Goetzke, Dipl.-Ing. (FH)</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wilhelminenspital</name>
      <address>
        <city>Vienna</city>
        <zip>1160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landesklinikum Wiener Neustadt</name>
      <address>
        <city>Wiener Neustadt</city>
        <zip>2700</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Universitaires Saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gentofte University Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NCN Nouvelles Cliniques Nantaises</name>
      <address>
        <city>Nantes Cedex 2</city>
        <zip>44277</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Hilaire Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>7600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Neu Bethlehem</name>
      <address>
        <city>Göttingen</city>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heinrich Braun Krankenhaus</name>
      <address>
        <city>Zwickau</city>
        <zip>08060</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Shatin</city>
        <state>New Territories</state>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Mater Domini Policlinico Universitario</name>
      <address>
        <city>Catanzaro</city>
        <state>CZ</state>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Casilino</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00169</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Jantung Negara</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Ziekenhuis</name>
      <address>
        <city>Breda</city>
        <zip>4818 CK</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rijnland Ziekenhuis</name>
      <address>
        <city>Leiderdorp</city>
        <zip>2353 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Y Provincial</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Universitaria de Navarra</name>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Clydebank</city>
        <zip>G81 4HX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2011</study_first_submitted>
  <study_first_submitted_qc>September 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2011</study_first_posted>
  <last_update_submitted>July 16, 2013</last_update_submitted>
  <last_update_submitted_qc>July 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pacemaker, CRT-P, auto threshold</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

